ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 66 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 469 | 0.0% | 0.00% | – |
Q2 2023 | $0 | -100.0% | 469 | 0.0% | 0.00% | – |
Q1 2023 | $1 | 0.0% | 469 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -99.9% | 469 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | -96.9% | 469 | -97.5% | 0.00% | – |
Q2 2022 | $32,000 | -56.2% | 18,878 | -46.8% | 0.00% | – |
Q1 2022 | $73,000 | -20.7% | 35,516 | +44.9% | 0.00% | -100.0% |
Q4 2021 | $92,000 | +15.0% | 24,515 | +59.4% | 0.00% | 0.0% |
Q3 2021 | $80,000 | +7900.0% | 15,382 | +5908.6% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 256 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 256 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 256 | -20.7% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 323 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 323 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | -50.0% | 323 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -50.0% | 323 | 0.0% | 0.00% | – |
Q3 2018 | $4,000 | 0.0% | 323 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | 0.0% | 323 | 0.0% | 0.00% | – |
Q1 2018 | $4,000 | – | 323 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 5,555,461 | $4,405,481 | 2.16% |
MPM BioImpact LLC | 5,095,912 | $4,041,058 | 0.94% |
NEA Management Company, LLC | 17,079,778 | $13,544,624 | 0.90% |
Syncona Portfolio Ltd | 1,377,294 | $1,092,194 | 0.69% |
PFM Health Sciences, LP | 10,423,135 | $8,265,546 | 0.50% |
TANG CAPITAL MANAGEMENT LLC | 4,387,238 | $3,479,080 | 0.32% |
Long Focus Capital Management, LLC | 12,086,915 | $9,584,924 | 0.32% |
Matrix Capital Management Company, LP | 38,974,185 | $30,906,529 | 0.32% |
Acuitas Investments, LLC | 479,789 | $380,473 | 0.20% |
Key Client Fiduciary Advisors, LLC | 336,620 | $266,940 | 0.16% |